Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins

BACKGROUND: A number of valuable candidates as tuberculosis vaccine have been reported, some of which have already entered clinical trials. The new vaccines, especially subunit vaccines, need multiple administrations in order to maintain adequate life-long immune memory: this demands for high produc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Microb Cell Fact
Main Authors: Piubelli, Luciano, Campa, Manuela, Temporini, Caterina, Binda, Elisa, Mangione, Francesca, Amicosante, Massimo, Terreni, Marco, Marinelli, Flavia, Pollegioni, Loredano
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225511/
https://ncbi.nlm.nih.gov/pubmed/24252280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2859-12-115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados